Jin Medical International Ltd (ZJYL)

$0.98

+0.1

(+11.1%)

Market is closed - opens 8 PM, 29 Nov 2024

Jin Medical International Ltd Key Statistics

Market Capitalization
$152.9M
Revenue TTM
$20.1M
EBITDA
$2.6M
Earnings Per Share (EPS)
$0.02
PE Ratio
48.83
Profit Margin
14.44%
Quarterly Earnings Growth YOY
-0.12%
Return On Equity TTM
11.33%

Jin Medical International Ltd share price movements

  • $0.83
    $1.00
    $0.98
    downward going graph

    15.31%

    Downside

    Day's Volatility :16.98%

    Upside

    1.98%

    downward going graph
  • $0.56
    $25.49
    $0.98
    downward going graph

    42.86%

    Downside

    52 Weeks Volatility :97.8%

    Upside

    96.16%

    downward going graph

Jin Medical International Ltd Returns

PeriodJin Medical International LtdIndex (Russel 2000)
3 Months
-64.23%
0.0%
6 Months
-68.19%
0.0%
1 Year
-17.41%
0.0%
3 Years
145.69%
-21.1%

Analyst Recommendation on Jin Medical International Ltd

Insights on Jin Medical International Ltd

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 9.56M → 5.27M (in $), with an average decrease of 44.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 1.11M → 897.04K (in $), with an average decrease of 19.3% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 73.3% return, outperforming this stock by 90.7%

Jin Medical International Ltd Financials in INR & Dollars

FY19Y/Y Change
Revenue
20.4M
-
Net Income
3.6M
-
Net Profit Margin
17.91%
-
FY20Y/Y Change
Revenue
16.2M
↓ 20.49%
Net Income
2.2M
↓ 39.52%
Net Profit Margin
13.62%
↓ 4.29%
FY21Y/Y Change
Revenue
20.8M
↑ 28.22%
Net Income
2.6M
↑ 19.3%
Net Profit Margin
12.67%
↓ 0.95%
FY22Y/Y Change
Revenue
19.2M
↓ 7.58%
Net Income
2.7M
↑ 2.84%
Net Profit Margin
14.1%
↑ 1.43%
FY23Y/Y Change
Revenue
19.8M
↑ 3.29%
Net Income
2.9M
↑ 6.34%
Net Profit Margin
14.52%
↑ 0.42%
FY24Y/Y Change
Revenue
19.8M
↑ 0.0%
Net Income
2.9M
↑ 0.0%
Net Profit Margin
14.52%
↑ 0.0%
Q3 FY22Q/Q Change
Revenue
4.9M
↑ 0.0%
Net Income
740.3K
↑ 0.0%
Net Profit Margin
15.23%
↑ 0.0%
Q4 FY22Q/Q Change
Revenue
5.1M
↑ 5.45%
Net Income
883.2K
↑ 19.29%
Net Profit Margin
17.23%
↑ 2.0%
Q2 FY23Q/Q Change
Revenue
4.8M
-
Net Income
555.9K
-
Net Profit Margin
11.62%
-
Q1 FY24Q/Q Change
Revenue
9.6M
↑ 100.0%
Net Income
1.1M
↑ 100.0%
Net Profit Margin
11.62%
↑ 0.0%
Q2 FY24Q/Q Change
Revenue
5.3M
↓ 44.83%
Net Income
897.0K
↓ 19.32%
Net Profit Margin
16.99%
↑ 5.37%
FY19Y/Y Change
Total Assets
20.4M
-
Total Liabilities
9.7M
-
FY20Y/Y Change
Total Assets
20.8M
↑ 2.23%
Total Liabilities
10.0M
↑ 3.69%
FY21Y/Y Change
Total Assets
21.9M
↑ 5.22%
Total Liabilities
7.9M
↓ 21.38%
FY22Y/Y Change
Total Assets
20.9M
↓ 4.39%
Total Liabilities
5.7M
↓ 27.54%
FY23Y/Y Change
Total Assets
32.9M
↑ 57.14%
Total Liabilities
8.9M
↑ 56.46%
FY24Y/Y Change
Total Assets
32.9M
↑ 0.0%
Total Liabilities
8.9M
↑ 0.0%
Q4 FY22Q/Q Change
Total Assets
31.0M
↑ 48.15%
Total Liabilities
7.5M
↑ 31.07%
Q1 FY23Q/Q Change
Total Assets
31.0M
↑ 0.0%
Total Liabilities
7.5M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
32.9M
↑ 6.06%
Total Liabilities
8.9M
↑ 19.37%
Q3 FY23Q/Q Change
Total Assets
32.9M
↑ 0.0%
Total Liabilities
8.9M
↑ 0.0%
Q1 FY24Q/Q Change
Total Assets
32.9M
↑ 0.0%
Total Liabilities
8.9M
↑ 0.0%
Q2 FY24Q/Q Change
Total Assets
41.2M
↑ 25.09%
Total Liabilities
15.0M
↑ 68.14%
FY19Y/Y Change
Operating Cash Flow
-1.3M
-
Investing Cash Flow
126.9K
-
Financing Cash Flow
2.4M
-
FY20Y/Y Change
Operating Cash Flow
2.5M
↓ 288.85%
Investing Cash Flow
-2.0M
↓ 1642.9%
Financing Cash Flow
-343.9K
↓ 114.56%
FY21Y/Y Change
Operating Cash Flow
5.8M
↑ 133.43%
Investing Cash Flow
-1.1M
↓ 45.49%
Financing Cash Flow
-2.9M
↑ 734.59%
FY22Y/Y Change
Operating Cash Flow
1.6M
↓ 72.95%
Investing Cash Flow
-120.9K
↓ 88.68%
Financing Cash Flow
121.9K
↓ 104.25%
Q3 FY22Q/Q Change
Operating Cash Flow
816.0K
↑ 0.0%
Investing Cash Flow
-40.0K
↑ 0.0%
Financing Cash Flow
64.2K
↑ 0.0%
Q4 FY22Q/Q Change
Operating Cash Flow
1.4M
↑ 68.11%
Investing Cash Flow
-3.5M
↑ 8732.57%
Financing Cash Flow
4.0M
↑ 6212.06%
Q1 FY23Q/Q Change
Operating Cash Flow
1.4M
↑ 0.0%
Investing Cash Flow
-3.5M
↑ 0.0%
Financing Cash Flow
4.0M
↑ 0.0%

Jin Medical International Ltd Technicals Summary

Sell

Neutral

Buy

Jin Medical International Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Jin Medical International Ltd Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Jin Medical International Ltd
Jin Medical International Ltd
-52.59%
-68.19%
-17.41%
145.69%
145.69%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
4.31%
35.18%
73.3%
60.89%
172.5%
Resmed Inc.
Resmed Inc.
2.02%
21.06%
56.96%
-2.95%
66.66%
Becton, Dickinson And Company
Becton, Dickinson And Company
-6.54%
-1.37%
-5.82%
-8.88%
-14.13%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
1.54%
0.15%
-7.34%
-27.73%
119.9%
Alcon Ag
Alcon Ag
-6.64%
0.98%
18.18%
12.41%
59.58%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Jin Medical International Ltd
Jin Medical International Ltd
48.83
48.83
NA
0.0
0.11
0.04
NA
0.17
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
87.0
87.0
4.02
6.84
0.16
0.08
NA
43.75
Resmed Inc.
Resmed Inc.
33.11
33.11
1.9
7.71
0.24
0.13
0.01
35.39
Becton, Dickinson And Company
Becton, Dickinson And Company
37.88
37.88
1.03
13.11
0.06
0.03
0.02
89.5
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
48.04
48.04
5.96
6.66
0.18
0.1
0.0
37.96
Alcon Ag
Alcon Ag
37.71
37.71
3.21
3.03
0.06
0.03
0.0
43.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Jin Medical International Ltd
Jin Medical International Ltd
NA
$152.9M
145.69%
48.83
14.44%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$191.8B
172.5%
87.0
28.51%
Resmed Inc.
Resmed Inc.
Buy
$36.6B
66.66%
33.11
23.15%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$64.2B
-14.13%
37.88
7.13%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.4B
119.9%
48.04
17.37%
Alcon Ag
Alcon Ag
Buy
$43.6B
59.58%
37.71
11.89%

About Jin Medical International Ltd

Organization
Jin Medical International Ltd
Employees
245
CEO
Mr. Erqi Wang
Industry
Miscellaneous

FAQs